MUC1 and interstitial lung disease: In this longitudinal retrospective and prospective cohort study, we evaluated QILD as an imaging biomarker that reliably correlated with PFT results, serum biomarker (KL-6), and radiologist’s measurements for interval ILD progression in patients with RA-ILD.